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Psychological and drug-related variables and their effect on the severity of withdrawal symptoms were examined in a group of addicts being withdrawn from opiates on an in-patient drug dependence unit. Two psychological factorsâ€"neuroticismand the degree of distress expected by the patientâ€"were related to subsequent severity of symptoms. Both areanxiety-related, and may serveto amplify withdrawal symptoms. Surprisingly, drug dose was unrelated to symptom severity.
A principal feature of opiate addiction is the with drawal syndrome, which is often regarded as one of the defining characteristics of such an addiction. The withdrawal syndrome is recognised and described in general terms in most accounts of addiction, but has not been fully investigated. There are many aspects of it that require further research. The fact that physiological symptoms such as increased perspiration, lacrimation, abdominal cramps, nausea, and diarrhoea are prominent features of withdrawal led the authors of early formu lations to emphasise its â€˜¿ physical' aspects; this is reflected in the use of the medical term â€˜¿ syndrome'. However, research has shown that psychological factors may also have a powerful effect on aspects of the withdrawal syndrome.
As early as 1927, Pavlov noted that classical con ditioning of morphine-induced responses had been observed by Krylov; subsequently, Wilder (1948) proposed a theory that relapse after detoxification was due in part to conditioned stimuli that elicit aspects of the withdrawal syndrome. Many studies have since confirmed this, and have extended under standing of the role of conditioning in the addictive disorders (O'Brien, 1976; O'Brien eta!, 1977; Siegel, 1979) . Kleber (1981) On admission, all subjects underwent a three-day assess ment period during which their need for opiates was assessed.
The initial daily dose level of methadone was established on the basis of clinical examination by a psy chiatrist and of nurses' observations. The response to this trial dose was closely monitored during a three-day period,
and if there were signs of intoxication or of opiate with drawal the dose was adjusted as necessary. All subjects were then withdrawn from their drug ofdependence over a 21-day period. During the withdrawal programme addicts received oral methadone three times a day on a linear reduction schedule. During the first 50 days they completed a self-report questionnaire designed to measure symptoms of opiate withdrawal. A version of this was used in the study reported by Gossop et a!, (1984) . The questionnaire contained 32 signs and symptoms; subjects were required to rate themselves on each item as it applied during the preceding 24 hours, using a four-point scale (nil, mild, moderate, severe). The 32 items were: feeling sick; vomiting; diarrhoea; poor appetite; dry mouth; stomach cramps; restlessness; eyes sensitive to light; headache; drowsiness; dizziness or giddiness; fainting attacks or lightheadedness; stiffness of arms and legs; spontaneous twitching (contraction) of muscles; trembling hands; feelings of coldness; feeling of unreality; â€˜¿ gooseflesh'; hot and cold flushes; increased sweating; runny nose; trouble starting urination; passing more than usual quantity of urine; heart pounding; fatigue or tiredness; muscular tension; aches and pains; weakness; yawning; sneezing, runny eyes; and insomnia.
At the time of admission all subjects completed a further brief questionnaire, in which they were asked to state on a four-point scale the severity of the withdrawal symptoms they expected to experience. They also completed the Eysenck Personality Questionnaire(EPQ) (Eysenck & Eysenck, 1975 with maximum withdrawal distress (r = â€"¿ 0.19).
Discussion
These results confirm Kleber's observation (1981) that psychological factors play a major role in the opiate withdrawal syndrome: in particular, they show that the personality factor of neuroticism and the addict's expectations about withdrawal are strongly related to the maximum level of withdrawal distress subsequently experienced during detoxification. Both these measures may be seen in broad terms as anxiety-related. Eysenck's neuroticism factor has been described as reflecting the reactivity and lability of the autonomic nervous system (Gossop, 1981); Eysenck & Rachman (1965) suggest that high neuroticism scorers are predisposed to respond more strongly, more lastingly, and more quickly with their autonomic nervous system when presented with stressful stimuli. In this respect, high levels of neuro ticism may act to amplify the response to opiate withdrawal. The same sort of process may also underlie the link between the addict's expectations about detoxification and his subsequent response to drug withdrawal.
Eiser & Gossop (1979) found that most addicts were extremely frightened of withdrawal, and believed that this was also true of other addicts. The present study shows that the more frightened of withdrawal the addict is, the more discomfort he is likely to report during the actual process of being withdrawn from drugs. It is interesting that in the regression analysis both the dose of methadone prescribed prior to the withdrawal programme and the length of opiate use were found to be unrelated to maximum levels of withdrawal distress, although there was a positive (but non-significant) correlation between duration of opiate use and withdrawal distress when simple correlation coefficients were calculated. Kleber (1981) suggests that duration of use may be related to withdrawal severity only up to a certain point, and that after two to three months it has little effect. It is more surprising that the dose of methadone was unrelated to severity. Kleber also states that the larger the daily dose of opiates, the more severe the withdrawal syndrome; this has been universally assumed, and seems almost self-evident; However, it is surprisingly difficult to find any empirical research to substantiate the claim. Several other definitive sources make the same link between dose and with drawal severity, but like Kleber fail to cite any refer ence to original research (Goodman & Gilman, 1980; Martindale, 1982; Wikler, 1980) . The findings of the present study, coupled with the lack ofempirical cvi dence, point to the need for further research to clarify this issue.
The main clinical implication of these results is that attention should be paid to the psychological state of the addict before and during the process of drug withdrawal. Research in other areas of medical psychology has shown that giving patients accurate information about what they may expect after surgical procedures reduces the pain and discomfort they subsequently experience (e.g. Melamed, 1977) . Similarly, providing accurate information reduces the distress experienced by subjects undergoing other painful procedures (Johnson, 1973; Leventhal el al, 1979) . However, the latter found that the way in which the briefing was phrased was an important variable; words such as â€˜¿ pain' could cancel the discomfort-reducing effect of the information. The response to drug withdrawal is similarly influenced by the extent of the patient's knowledge of and participation in the withdrawal procedure. Stitzer et al, (1982) found that knowledge of the dose reduction schedule serves to reduce symptom complaints, and they suggest that much of the withdrawal sympto matology may be a result of anxiety and uncertainty. These findings, together with those of the present study, suggest that when withdrawing addicts from opiates, providing the individual with information about the sort of intensity of symptoms that might occur could reduce withdrawal distress, but that this issue deserves further investigation.
